Gedea Biotech AB
Quotes
Share:
Subscribe:

Annette Säfholm CEO Gedea Biotech

Wed, Nov 15, 2023 12:55 CET

Photographer: Fotograf

Medium resolution

Original resolution

Subscribe

Related Releases

Gedea Biotech receives approval to initiate the pivotal NEFERTITI-2 clinical study documenting the performance of pHyph for treatment of bacterial vaginosis Wed, Nov 08, 2023 13:00 CET

Gedea Biotech granted European Patent for the formulation of its vaginal pHyph tablet for women with vaginal infections Wed, Sep 13, 2023 08:30 CET

Gedea Biotech secures 1.3 MEuros (14 MSEK) to advance its antibiotic-free vaginal infection treatment pHyph towards market launch Wed, May 24, 2023 08:30 CET